Analyzing the forecast for the average length of stay for alcoholic liver disease cases in Canadian hospitals, data from 2024 to 2028 suggests a slight but consistent decline. In 2023, the average stay was 11.6 days. The predicted reduction to 11.3 days by 2028 represents a cumulative decrease of about 2.59% over five years, with a CAGR of approximately -0.53%. This indicates ongoing improvements in treatment or management efficiency.
Future trends to watch for include advancements in liver disease therapies, shifts in healthcare policy impacting treatment protocols, and lifestyle changes that might affect the prevalence and management of liver disease, potentially leading to further reductions in stay lengths.
